Reduction of abdominal hydatid disease with prolonged treatment

American Journal of Gastroenterology

Volumn 92, Issue 7, 1997, Pages 1231-1232

  Jover, Rodrigo ^a   Gutiérrez, Ana ^a   De Zárate, Victoria ^a   Zaragoza, Jaime ^a   Martínez, Juan ^a   Pérez Mateo, Miguel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT;

ABDOMINAL MASS; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ECHINOCOCCOSIS; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ALBENDAZOLE; ANTHELMINTICS; ECHINOCOCCOSIS; ECHINOCOCCOSIS, HEPATIC; FEMALE; HUMANS; PERITONEAL DISEASES; SPLENIC DISEASES;

EID: 0030849902     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of the efficacy of albendazole in intra-abdominal hydatid disease. Lancet 1993;342:1269-72.
2. Morris DL. Echinococcus of the liver. Gut 1994;35:1517-8.
3. Saimot AG, Meulemans A, Cremieux AC, et al. Albendazole as a potential treatment for human hydatidosis. Lancet 1983;2:652-6.
4. Khuroo MS, Dar MY, Yattoo GN, et al. Percutaneous drainage versus albendazole therapy in hepatic hidatidosis: A prospective, randomized study. Gastroenterology 1993;104:1452-9.
5. Todorov T, Vutova G, Mechkov G, et al. Evaluation of response to chemotherapy of human cystic echinococcosis. Br J Radiol 1990;63: 523-31.